Drugs / chlorpheniramine tannate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01008397 | Apr 2011 | seasonal allergic rhinitis | Magna Pharmaceuticals, Inc. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | chlorpheniramine tannate | “Oral tablet containing chlorpheniramine tannate 12mg.” NCT01008397 ↗ |
| Route | Oral | “Oral tablet containing chlorpheniramine tannate 12mg.” NCT01008397 ↗ |